The only observed truncating mutation was TINF2 p.Tyr312Ter, and although it was more prevalent in cases compared to controls, it is unlikely a high cancer risk allele analogous to those TINF2 truncation mutations previously described in the literature [6, 7]. Here, TINF2 is linked to cancer.